Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111988) titled 'Valbenazine in Obsessive Compulsive Disorder' on Aug. 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: University of Chicago

Condition: Obsessive-Compulsive Disorder

Intervention: Drug: Valbenazine

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 2025

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111988

Published by HT Digital Content Services w...